Currently browsing ADHD Treatment Publications


Safety and Effectiveness of Guanfacine Hydrochloride Extended-Release in Adult Patients with ADHD in Japan: A Post-Marketing Surveillance Study

CONCLUSIONS: No ADRs requiring new safety measures were observed. The effectiveness of GXR in adult ADHD was evident among patients remaining on treatment. via https://pubmed.ncbi.nlm.nih.gov/42159952/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260601010905&v=2.20.0

Suggested reading

SYNCRIP-Related Neurodevelopmental Disorder

CLINICAL CHARACTERISTICS: SYNCRIP-related neurodevelopmental disorder (SYNCRIP-NDD) is characterized by borderline-to-moderate developmental delay / intellectual disability, neurobehavioral/psychiatric manifestations (autism spectrum disorder, attention-deficit/hyperactivity disorder, and/or sleep disturbances), ocular and vision anomalies, and…

Suggested reading